Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Rossi Christina
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Hurley Ariel
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Haviland Kate
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Rossi Christina
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director COATS LONNEL
Blueprint Medicines | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(8.5%)
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Namouni Fouad
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Landsittel Michael
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Lee Philina
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Carter Percy H.
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Rossi Christina
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Durso-Bumpus Debra
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Durso-Bumpus Debra
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Durso-Bumpus Debra
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director COATS LONNEL
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Beckman Daniella
No Data